- Year 2023 in review - Chronic pain treatment2023 | First Faculty of Medicine
- Safety signals of 17-OHP-C use in pregnancy and efficacy in the prevention of preterm birth2009 | First Faculty of Medicine
- Very low nicotine cigarettes: will they really lower the risk?2022 | First Faculty of Medicine
- Melanoma associated with tumour necrosis factor-α inhibitors: a Research on Adverse Drug events And Reports (RADAR) project2014 | Faculty of Medicine in Pilsen
- Quality, control and validation of glucometers and CGM systems. Status overview2016 | First Faculty of Medicine
- What news brought last year on oral antidiabetic drugs?2016 | First Faculty of Medicine, Third Faculty of Medicine
- Current and Novel Inhibitors of HIV Protease2009 | Faculty of Science, Third Faculty of Medicine
- Nivolumab in treatment of NSCLC2016 | Publication without faculty affiliation
- Case studies of patients treated with osimertinib2019 | Second Faculty of Medicine
- Natalizumab2007 | First Faculty of Medicine
- Eva Kopečná, Jiří Paseka, Anetta Jedličková: Monitoring, audit and inspection in clinical evaluation2009 | First Faculty of Medicine
- Results of large cardiology-diabetic studies in recent years (EXAMINE, ORIGIN, SAVOR)2014 | Second Faculty of Medicine
- Role of ruxolitinib in the treatment of primary myelofibrosis2015 | Faculty of Medicine in Hradec Králové
- BRAF mutation: a novel approach in targeted melanoma therapy2012 | Third Faculty of Medicine
- Proteasome inhibitors in the treatment of multiple myeloma2021 | Faculty of Medicine in Hradec Králové
- Citalopram and QT prolongation2017 | Publication without faculty affiliation
- Current application of ritusimab in pharmacotherapy2015 | Publication without faculty affiliation
- Multiple sclerosis2010 | First Faculty of Medicine
- Current therapeutic options for multiple sclerosis2010 | First Faculty of Medicine
- Immunotherapy in treatment of lung cancer2016 | Publication without faculty affiliation
- Pembrolizumab in the treatment of non-small-cell lung cancer2016 | Publication without faculty affiliation
- Lung damage in systemic sclerosis, new indication of antifibrotic treatment with nintedanib2020 | Faculty of Medicine in Hradec Králové
- Iloperidone2011 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Friedreich's Ataxia: Treatment on the Horizon!2023 | First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
- New injuries - new risks - new procedures2008 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Where are we going to estimate ethical borders of biomedical research?2011 | Publication without faculty affiliation
- Immunotherapy in lung cancer treatment2016 | Publication without faculty affiliation
- Case report of a patient with generalized NSCLC with high PD-L1 expression treated with pembrolizumab2020 | Publication without faculty affiliation
- IIpilimumab in the treatment of melanoma2014 | Third Faculty of Medicine
- Polyangiitis microscopica - a rare necrotizing vasculitis2013 | First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
